Shire Plc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

iCD Research
February 6, 2012
46 Pages - SKU: ICDR6792501
License type:
Synopsis

ICD Research's Shire Plc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

ICD Research's Shire Plc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Shire Plc.

ICD Research's Shire Plc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about Shire Plc for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance and competitive benchmarking.
  • The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of Shire Plc .
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

Shire plc (Shire) is one of world's leading specialty biopharmaceutical companies based in the UK. The company engages in the research, development and commercialization of pharmaceutical products across the therapeutic areas including Central Nervous System (CNS), gastro-intestinal, and human genetic therapies, among others. It also focuses on acquiring in-licensing rights or companies for the products in specialist markets with strong intellectual property protection and global rights. The company's major products include VYVANSE, INTUNIV, EQUASYM, RESOLOR, PENTASA, LIALDA, FOSRENOL, CALCICHEW, REPLAGAL, ELAPRASE and XAGRID. Major products in the pipeline are JUVISTA, SPD 547, and HGT-1110, among others. Its products are extensively used in treating ADHD (attention deficit and hyperactivity disorder). The company has main operations across the US, Canada, the UK, Republic of Ireland, France, Germany, Italy and Spain. Shire is headquartered in Basingstoke, the UK.